Paper41548856
Avenues for optimization of cardiac therapeutics by minimally invasive delivery.
Li Y and 3 others. Acta Biomater, 2026. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Avenues for optimization of cardiac therapeutics by minimally invasive delivery. Papers, record 41548856. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41548856
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL146153 | NHLBI NIH HHS | United States | R01HL146153 | PubMed | NIH RePORTER |
| R01 HL144002 | NHLBI NIH HHS | United States | R01HL144002 | PubMed | NIH RePORTER |
| R01 HL076485 | NHLBI NIH HHS | United States | R01HL076485 | PubMed | NIH RePORTER |
| P41 EB027062 | NIBIB NIH HHS | United States | P41EB027062 | PubMed | NIH RePORTER |
| R01 HL154154 | NHLBI NIH HHS | United States | R01HL154154 | PubMed | NIH RePORTER |
| R01 HL170612 | NHLBI NIH HHS | United States | R01HL170612 | PubMed | NIH RePORTER |
References217
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24700706 | Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. | Circulation | 2014 | https://conductscience.org/library/papers/24700706 | PubMed |
| 2 | 33500578 | Targeted delivery of therapeutic agents to the heart. | Nat Rev Cardiol | 2021 | https://conductscience.org/library/papers/33500578 | PubMed |
| 3 | 28267588 | Initial international multicenter human experience with a novel epicardial access needle embedded with a real-time pressure/frequency monitoring to facilitate epicardial access: Feasibility and safety. | Heart Rhythm | 2017 | https://conductscience.org/library/papers/28267588 | PubMed |
| 4 | 38885303 | Advanced Cardiac Patches for the Treatment of Myocardial Infarction. | Circulation | 2024 | https://conductscience.org/library/papers/38885303 | PubMed |
| 5 | 35077739 | Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles. | J Control Release | 2022 | https://conductscience.org/library/papers/35077739 | PubMed |
| 6 | 34793116 | Extruded Mesenchymal Stem Cell Nanovesicles Are Equally Potent to Natural Extracellular Vesicles in Cardiac Repair. | ACS Appl Mater Interfaces | 2021 | https://conductscience.org/library/papers/34793116 | PubMed |
| 7 | 26375005 | Epicardial FSTL1 reconstitution regenerates the adult mammalian heart. | Nature | 2015 | https://conductscience.org/library/papers/26375005 | PubMed |
| 8 | 11980678 | Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. | Circulation | 2002 | https://conductscience.org/library/papers/11980678 | PubMed |
| 9 | 12169644 | Differentiation of pluripotent embryonic stem cells into cardiomyocytes. | Circ Res | 2002 | https://conductscience.org/library/papers/12169644 | PubMed |
| 10 | 27668147 | Injectable Hydrogels for Cardiac Tissue Repair after Myocardial Infarction. | Adv Sci (Weinh) | 2015 | https://conductscience.org/library/papers/27668147 | PubMed |
| 11 | 28875984 | Multiscale technologies for treatment of ischemic cardiomyopathy. | Nat Nanotechnol | 2017 | https://conductscience.org/library/papers/28875984 | PubMed |
| 12 | 25119045 | A long noncoding RNA protects the heart from pathological hypertrophy. | Nature | 2014 | https://conductscience.org/library/papers/25119045 | PubMed |
| 13 | 40306855 | Delaying Drug Release: A Time Capsule for the Heart. | JACC Basic Transl Sci | 2025 | https://conductscience.org/library/papers/40306855 | PubMed |
| 14 | 28596337 | Cardiac regeneration strategies: Staying young at heart. | Science | 2017 | https://conductscience.org/library/papers/28596337 | PubMed |
| 15 | 28045024 | Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. | Nat Commun | 2017 | https://conductscience.org/library/papers/28045024 | PubMed |
| 16 | 33627421 | Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs. | Sci Adv | 2021 | https://conductscience.org/library/papers/33627421 | PubMed |
| 17 | 27324127 | Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. | Cell Tissue Res | 2016 | https://conductscience.org/library/papers/27324127 | PubMed |
| 18 | 29330085 | Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. | Pharmacol Ther | 2018 | https://conductscience.org/library/papers/29330085 | PubMed |
| 19 | 39831819 | Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity. | Eur Heart J | 2025 | https://conductscience.org/library/papers/39831819 | PubMed |
| 20 | 37192972 | Therapeutic angiogenesis based on injectable hydrogel for protein delivery in ischemic heart disease. | iScience | 2023 | https://conductscience.org/library/papers/37192972 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42445832 | Controlled Delivery of Gasotransmitters for Cardiovascular Therapy: Molecular Mechanisms, Engineered Platforms, and Translational Perspectives. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42445832 | PubMed |
| 42403926 | Immune cell-derived membrane nanovesicles: A promethean fire for autoimmune disease therapy through immune cell mimicry. | Bioact Mater | 2026 | https://conductscience.org/library/papers/42403926 | PubMed |
| 42166700 | Intrapericardially injected hydrogel loaded with stromal cell secretome microparticles improves post-infarction myocardial repair in pigs. | Eur Heart J | 2026 | https://conductscience.org/library/papers/42166700 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41548856
GET https://conductscience.org/api/papers/v1/41548856/references?page=2